HGM has informed the Exchange regarding Board meeting held on August 20, 2025, approved an acquisition.
HGM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
HGM Limited's board has approved the acquisition of 100% equity in Aidéo Technologies LLC, a US-based AI-driven autonomous medical coding company in the revenue cycle management (RCM) space. The deal will be executed through its wholly owned US subsidiary, Healthcare Capital Holdings LLC (HCH), via issuance of HCH Class B Preferred Stock for a total consideration of up to Rs. 14.08 Crores (non-cash). Aidéo reported revenue of Rs. 18.96 Crore in FY24, up from Rs. 11.70 Crore in FY23 and Rs. 7.44 Crore in FY22, showing strong growth. The acquisition is expected to close on August 20, 2025, and no prior regulatory approvals are required. Management views this as a key step toward building a comprehensive AI-driven healthcare services platform in the US.
This acquisition strengthens HGM's presence in the AI-powered healthcare services segment and adds a fast-growing US asset (revenue up ~62% YoY in FY24) to its portfolio. For shareholders, it signals a strategic pivot/investment into AI-led healthcare automation, though the deal is small (Rs. 14 Cr) and non-cash, so immediate impact on stock price is likely limited to sentiment.